UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 71

Sortiert nach

Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study

Journal of clinical oncology, 2013-03, Vol.31 (7), p.853-859

2013

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of cancer and management in elderly nursing home residents. A descriptive study in 45 French nursing homes

European journal of cancer care, 2019-03, Vol.28 (2), p.e12957-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

STAT3 is essential for the maintenance of neurosphere‐initiating tumor cells in patients with glioblastomas: A potential for targeted therapy?

International journal of cancer, 2011-02, Vol.128 (4), p.826-838

2011

Link zum Volltext

Verfügbarkeit prüfen

Assessing 2-Month Clinical Prognosis in Hospitalized Patients With Advanced Solid Tumors

Journal of clinical oncology, 2008-05, Vol.26 (15), p.2538-2543

2008

Link zum Volltext

Verfügbarkeit prüfen

O6-Methylguanine-methyltransferase (MGMT) promoter methylation status in glioma stem-like cells is correlated to temozolomide sensitivity under differentiation-promoting conditions

International journal of molecular sciences, 2012-06, Vol.13 (6), p.6983-6994

2012

Link zum Volltext

Verfügbarkeit prüfen

Multicenter Study of a Frozen Glove to Prevent Docetaxel-Induced Onycholysis and Cutaneous Toxicity of the Hand

Journal of clinical oncology, 2005-07, Vol.23 (19), p.4424-4429

2005

Link zum Volltext

Verfügbarkeit prüfen

Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies

Annals of neurology, 1999-02, Vol.45 (2), p.162-167

1999

Link zum Volltext

Verfügbarkeit prüfen

Preliminary results of the Prostacox phase II trial in hormonal refractory prostate cancer

BJU international, 2007-10, Vol.100 (4), p.770-774

2007

Link zum Volltext

Verfügbarkeit prüfen

Reply to the Letter to the Editor Entitled “Vinflunine for Non-small Cell Lung Cancer: Realistic Hopes?”

Journal of thoracic oncology, 2011-10, Vol.6 (10), p.1777-1778

Tourani, Jean-Marc

2011

Link zum Volltext

Verfügbarkeit prüfen

Supportive Care Organization in France: a national in-depth survey among patients and oncologists

Supportive care in cancer, 2017-07, Vol.25 (7), p.2111-2118

2017

Link zum Volltext

Verfügbarkeit prüfen

Safety and outcome of chemoradiotherapy in elderly patients with rectal cancer: Results from two French tertiary centres

Digestive and liver disease, 2012-04, Vol.44 (4), p.350-354

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of pemetrexed and cisplatin with concurrent high-dose thoracic radiation after induction chemotherapy in patients with unresectable locally advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2013-04, Vol.80 (1), p.68-74

2013

Link zum Volltext

Verfügbarkeit prüfen

Matched case‐control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel‐induced onycholysis and cutaneous toxicity of the foot

Cancer, 2008-04, Vol.112 (7), p.1625-1631

2008

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

The New England journal of medicine, 2019-03, Vol.380 (12), p.1116-1127

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase I and pharmacokinetic study of IV vinflunine in combination with carboplatin in chemonaive patients with advanced non-small cell lung cancer

American journal of clinical oncology, 2012-08, Vol.35 (4), p.378-385

2012

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

The lancet oncology, 2021-04, Vol.22 (4), p.463-475

2021

Link zum Volltext

Verfügbarkeit prüfen

Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma

Cancer research (Chicago, Ill.), 1992-06, Vol.52 (12), p.3317-3322

1992

Link zum Volltext

Verfügbarkeit prüfen

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

The lancet oncology, 2020-12, Vol.21 (12), p.1574-1588

2020

Link zum Volltext

Verfügbarkeit prüfen

Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study

The lancet oncology, 2024-02, Vol.25 (2), p.255-264

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(71)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(48)
Science & Technology
(48)
Humans
(45)
Female
(38)
Male
(38)
Oncology
(35)
Middle Aged
(34)
Aged
(32)
Adult
(25)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(15)
Treatment Outcome
(14)
Aged, 80 And Over
(10)
Chemotherapy
(10)
Prognosis
(10)
Tumors
(10)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(9)
Life Sciences
(9)
Pharmacology. Drug Treatments
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study

Afatinib maintenance therapy following post-operative radiochemotherapy in head and neck squamous cell carcinoma: Results from the phase III randomised double-blind placebo-controlled study BIB2992ORL (GORTEC 2010–02)

Prevalence of cancer and management in elderly nursing home residents. A descriptive study in 45 French nursing homes

STAT3 is essential for the maintenance of neurosphere‐initiating tumor cells in patients with glioblastomas: A potential for targeted therapy?

Assessing 2-Month Clinical Prognosis in Hospitalized Patients With Advanced Solid Tumors

O6-Methylguanine-methyltransferase (MGMT) promoter methylation status in glioma stem-like cells is correlated to temozolomide sensitivity under differentiation-promoting conditions

Multicenter Study of a Frozen Glove to Prevent Docetaxel-Induced Onycholysis and Cutaneous Toxicity of the Hand

Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial

Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial

Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial

Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies

Preliminary results of the Prostacox phase II trial in hormonal refractory prostate cancer

Reply to the Letter to the Editor Entitled “Vinflunine for Non-small Cell Lung Cancer: Realistic Hopes?”

Subcutaneous Interleukin-2 and Interferon Alfa Administration in Patients With Metastatic Renal Cell Carcinoma: Final Results of SCAPP III, a Large, Multicenter, Phase II, Nonrandomized Study With Sequential Analysis Design—The Subcutaneous Administration Propeukin Program Cooperative Group

Supportive Care Organization in France: a national in-depth survey among patients and oncologists

Safety and outcome of chemoradiotherapy in elderly patients with rectal cancer: Results from two French tertiary centres

Phase I study of pemetrexed and cisplatin with concurrent high-dose thoracic radiation after induction chemotherapy in patients with unresectable locally advanced non-small cell lung cancer

Matched case‐control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel‐induced onycholysis and cutaneous toxicity of the foot

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Phase I and pharmacokinetic study of IV vinflunine in combination with carboplatin in chemonaive patients with advanced non-small cell lung cancer

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study

Suchergebnisse filtern